Skip to main content

Table 3 Median Tolerabiliy, inhalation time, cleaning and integration into the conventional therapy comparing jet nebuliser and eFlow® rapid; n = 70 patients

From: Lung function in adult patients with cystic fibrosis after using the eFlow® rapid for one year

 

Jet nebuliser

eFlow®® rapid

p

Tolerability

9 (2-10)

10 (5-10)

0.021

Inhalation time

3 (1-10)

10 (3-10)

< 0.01

Cleaning

7 (1-10)

7 (1-10)

0.93

Integration

7 (1-10)

7 (1-10)

0.95

  1. All data were presented as median (range). Both treatment devices were compared using the Wilcoxon test with exact probabilities.